Markets › United States › NAS › ADMA

ADMA Biologics Inc

NAS:ADMAHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$11.07+3.65%At closeAt close · Tue 20 Oct · ≈ AED 40.65 · Market cap $2.48B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−45.2%	1.4%	22.9%	34.4%	51.5%	57.4%	—	—
Operating margin	−153.8%	−72.1%	−25.5%	8.4%	32.6%	37.5%	37.5%	+0.0 pts
Net margin	−179.4%	−88.5%	−42.8%	−10.9%	46.4%	28.8%	28.8%	+0.0 pts
EBITDA margin	−141.7%	−65.6%	−25.6%	2.0%	34.6%	38.8%	—	—
Return on equity	−85.8%	−50.8%	−43.4%	−20.9%	56.6%	30.8%	30.8%	+0.0 pts
Return on assets	−36.5%	−25.9%	−18.9%	−8.6%	40.5%	23.5%	23.5%	+0.0 pts
Return on capital employed	−34.6%	−23.7%	−12.7%	7.7%	32.1%	34.5%	—	—
Debt / equity	1.1×	0.7×	1.0×	1.0×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	47.0%	37.3%	44.3%	43.0%	16.8%	12.8%	—	—
Interest coverage	−5.4×	−4.5×	−2.0×	0.9×	10.0×	26.9×	—	—
Current ratio	7.7×	6.9×	6.9×	5.2×	6.0×	6.7×	6.7×	+0.0%
Quick ratio	3.6×	2.8×	2.7×	1.7×	2.9×	3.7×	—	—
Cash ratio	2.8×	1.7×	2.2×	1.0×	1.9×	1.3×	1.3×	+0.0%
Asset turnover	0.2×	0.3×	0.4×	0.8×	0.9×	0.8×	—	—
Inventory turnover	0.8×	0.6×	0.7×	1.0×	1.2×	1.1×	—	—
Receivables turnover	3.2×	2.8×	9.9×	9.4×	8.5×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—